Next, we evaluated the potential protective effect of BHA in the acute model of systemic inflammatory response syndrome (SIRS) caused by intravenous injection of TNF, a lethal shock model previously demonstrated to originate from RIPK1 kinase-dependent cell death [53, 54]. The gene discussed is TNF; the disease is systemic inflammatory response syndrome.